
Share
16th January 2016
12:03pm GMT

"The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Diego Brandao of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol ("Carboxy-THC") which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected following his fight on January 2, 2016 in Las Vegas."
The statement also says that the USADA will share their info with the Nevada State Athletic Commission in order to determine the appropriate punishment for the Brazilian.
Explore more on these topics: